neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 6.295

+2.1%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Terry Lyon who wrote (321)	4/11/1999 8:02:00 PM
From: Kramer	Read Replies (1) of 441

idxx is mostly human clinical. I don't know of any company that broadly competes with neog. Last time I looked idxx had allot of cash and I wondered if they might be interested in acquiring neog as well as companies like 3M or Dupont. Although neog in the last conference call talked like they were going to grow much bigger through acquisition because in regards to one of the questions about wasting cash buying back stock their answer was that after an acquisition their still would be that many fewer shares. To me that answer means that they are referring to an acquisition with a stock deal/exchange that must be greater than their $20 million dollars of buying power otherwise that answer wouldn't make sense. Of course that would be welcome news, neog greatly needs a larger market cap, we need a deal like that to get to $20, as long as the deal is accretive, and knowing how frugal neog's management is, they wouldn't do a deal that wasn't. Regards,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next